7th NovAliX Conference

Biophysics in Drug Discovery 2019 | Asian Edition

Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs

 Kyoto, Japan    November 13-15, 2019

Keynote Speaker

From Fragments to Pharmaceuticals

Dr Harren JHOTI
ASTEX THERAPEUTICS, Cambridge, United Kingdom
Read more

Confirmed Speakers

Prof. Gerard BRICOGNE
GLOBAL PHASING LTD., Cambridge, United Kingdom

Advancing Drug Discovery in Pharma Using Cryo-EM

Dr Claudio CIFERRI
GENENTECH, South San Francisco, United States
Read more

Structure-biophysics Driven PROTAC Design for Degrading Undruggable Cancer Targets

Prof. Alessio CIULLI
UNIVERSITY OF DUNDEE, Dundee, United Kingdom
Read more

Enabling Drug Discovery with Crude Reaction Mixture Screening

Dr Ben DAVIS
VERNALIS RESEARCH, Cambridge, United Kingdom
Read more

PhABits – Shining New Light on Fragments Methodology for Tractability

Dr Michael HANN
GSK MEDICINES RESEARCH CENTRE, Stevenage, United Kingdom
Read more

Applying Hybrid Biophysical and Structural Methods to Study Allosteric Regulation

Dr Herbert NAR
BOEHRINGER INGELHEIM, Biberach, Germany
Read more

Prof. Daniela RHODES
NANYANG TECHNOLOGICAL UNIVERSITY, Singapore, Singapore

Advancing Cryo-EM for Determination of G Protein-coupled Receptor Structure

Prof. Patrick M. SEXTON
MONASH UNIVERSITY, Parkville, Australia
Read more

Structural Studies of the Yeast Fatty Acid Synthase. The Discovery of a Novel and Overlooked Subunit

Prof. Holger STARK
MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY, Göttingen, Germany
Read more

Ligand-Based Fluorine NMR Screening in Drug Discovery

Dr Anna VULPETTI
NOVARTIS, Basel, Switzerland
Read more